Implications of Gender-Affirming Hormone Therapy for Psychosocial Functioning and Social Relationships of Transgender People
This project aims to investigate the psychosocial effects of gender-affirming hormone therapy on transgender individuals, linking biological, psychological, and social factors to improve health equity and inform policy.
Projectdetails
Introduction
Transgender health is an area of increasing focus for researchers and medical practitioners across Europe, in part due to rapidly escalating numbers of people identifying as transgender. A crucial oversight in this area is that very little research has examined how gender-affirming hormone therapy, the most common form of medical intervention for transgender people, shapes psychosocial functioning and ultimately social relationship experiences.
Importance of Social Relationships
Given the paramount importance of social relationships to health and well-being, evidence for psychosocial effects of gender-affirming hormone therapy is vital to ensuring health equity for transgender people, who suffer from alarmingly high rates of social disruption and suicide risk.
Proposed Model
I draw together independent strands of research on biological effects of hormones from social neuroendocrinology and health influences of psychological and sociocultural factors from social psychology and epidemiology to propose a novel biopsychosocial model linking gender-affirming hormone therapy to psychosocial functioning in transgender people.
Research Programme
Drawing upon this model, I propose a programme of research involving four complementary work packages, triangulating across a variety of novel and cutting-edge research methods. This work will be guided by three key aims:
- To isolate causal pathways from a biopsychosocial model linking gender-affirming hormone therapy to psychosocial functioning.
- To empower transgender people to give voice to their own personal and relational experiences in the context of gender-affirming hormone therapy.
- To guide policy and practice for gender identity services in line with the informed consent model, directing focus to the improvement of psychosocial functioning and social relationship outcomes.
Conclusion
This interdisciplinary programme of research will sit at the forefront of gender-affirming healthcare and treatment for transgender people.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.500.000 |
Totale projectbegroting | € 1.500.000 |
Tijdlijn
Startdatum | 1-1-2023 |
Einddatum | 31-12-2027 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- STICHTING AMSTERDAM UMCpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Changing landscapes: hormonal fluctuations and neurocognitive functioning across the female lifespanThis project investigates how hormonal fluctuations during puberty, menstrual cycles, and menopause affect neurocognitive functioning in women using a multidisciplinary approach. | ERC Consolid... | € 2.000.000 | 2024 | Details |
Hormone-microbiome interactions as a key-player in female healthThis project aims to investigate hormone-microbiome interactions in women to understand their impact on health and infertility, ultimately identifying biomarkers and new therapeutic strategies. | ERC Starting... | € 1.499.485 | 2022 | Details |
From face-to-face to face-to-screen: Social animals interacting in a digital worldThis project examines the impact of face-to-screen interactions on social bonding and hormone engagement, aiming to enhance digital interactions through experimental and biopsychological methods. | ERC Starting... | € 1.499.377 | 2023 | Details |
Challenging the gender binary: Empirically unravelling the limitation of the male-female categoriesThis project aims to challenge the binary view of sex and gender by analyzing psychological components and promoting a diverse understanding of identity beyond traditional male-female categories. | ERC Advanced... | € 2.446.001 | 2022 | Details |
Gut microbiome-mediated activities of psychotropic drugsThis project aims to explore the role of gut microbiomes in the efficacy and side effects of psychotropic drugs, potentially revolutionizing personalized drug therapy for mental illnesses. | ERC Starting... | € 1.497.033 | 2024 | Details |
Changing landscapes: hormonal fluctuations and neurocognitive functioning across the female lifespan
This project investigates how hormonal fluctuations during puberty, menstrual cycles, and menopause affect neurocognitive functioning in women using a multidisciplinary approach.
Hormone-microbiome interactions as a key-player in female health
This project aims to investigate hormone-microbiome interactions in women to understand their impact on health and infertility, ultimately identifying biomarkers and new therapeutic strategies.
From face-to-face to face-to-screen: Social animals interacting in a digital world
This project examines the impact of face-to-screen interactions on social bonding and hormone engagement, aiming to enhance digital interactions through experimental and biopsychological methods.
Challenging the gender binary: Empirically unravelling the limitation of the male-female categories
This project aims to challenge the binary view of sex and gender by analyzing psychological components and promoting a diverse understanding of identity beyond traditional male-female categories.
Gut microbiome-mediated activities of psychotropic drugs
This project aims to explore the role of gut microbiomes in the efficacy and side effects of psychotropic drugs, potentially revolutionizing personalized drug therapy for mental illnesses.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Digitale transformatie data acquisitie en verwerking van klinische onderzoekenTherapySelector ontwikkelt een AI-gestuurde oplossing om het selectieproces van medische publicaties te versnellen en te digitaliseren, met als doel persoonsgericht medicatievoorschrijven te verbeteren. | Mkb-innovati... | € 20.000 | 2021 | Details |
Digitale transformatie data acquisitie en verwerking van klinische onderzoeken
TherapySelector ontwikkelt een AI-gestuurde oplossing om het selectieproces van medische publicaties te versnellen en te digitaliseren, met als doel persoonsgericht medicatievoorschrijven te verbeteren.